Comorbidities in gout and hyperuricemia: causality or epiphenomena?

Area of Science:

• Rheumatology
• Epidemiology
• Genetics

Background:

• Gout and hyperuricemia are frequently associated with comorbidities like chronic kidney disease and metabolic syndrome.
• Observational studies suggest links between gout and comorbidities, but confounding factors complicate causal inference.

Purpose of the Study:

• To review advances in understanding potentially causal relationships between gout, hyperuricemia, and associated comorbidities.
• To evaluate the evidence for causal links using genetic approaches like Mendelian randomization.

Main Methods:

• Review of observational studies identifying comorbidity clusters in gout patients.
• Application of Mendelian randomization to assess causal relationships between serum urate and comorbid traits using genetic variants as instrumental variables.

Main Results:

• Mendelian randomization studies have not supported widespread causal relationships between serum urate and most comorbid traits.
• Body mass index (BMI) shows a small causal effect on serum urate, potentially explaining some comorbidity prevalence.
• Limited robust Mendelian randomization studies exist for gout and its comorbidities, including hypertension.

Conclusions:

• Current Mendelian randomization evidence suggests serum urate may not causally influence gout comorbidities.
• Further research is required to elucidate the specific causal role of gout itself in the development of associated conditions.